| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001082938A3 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001064685A3 Thienopyridine derivatives and their use as anti-inflammatory agents |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/08/2002 | US20020107280 Selective COX II inhibitor |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107263 Squaric acid derivatives |
| 08/08/2002 | US20020107257 Treatments for restless legs syndrome |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107252 Novel Compounds |
| 08/08/2002 | US20020107251 4-(hetero)aryl-3-oxo-3,4-dihydropyrido(2,3-b)pyrazine derivatives; prophylactic or therapeutic treatment of phosphodiesterase IV and tumor necrosis factor mediated diseases |
| 08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107239 Cyclized amide derivatives |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107188 By injecting somatotropin, preferably in purified form, in a buffer solution, and injecting one time or multiple repeat times |
| 08/08/2002 | US20020106793 Tissue engineering scaffolds promoting matrix protein production |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106362 Method for the treatment of chemonucleolysis |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1229024A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRIN ALPHA-V BETA-3 ANTAGONISM |
| 08/07/2002 | EP1228761A2 Liquid pharmaceutical composition for treating bone diseases |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228066A2 Sulfonamide derivatives |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227846A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227832A2 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227814A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362881A Inflammatory mediation obtained from atractylodes lancea |
| 08/07/2002 | CN1362256A Osteological Chinese medicine prepn. |
| 08/07/2002 | CN1362202A Spur and rheumatism treating plaster |
| 08/07/2002 | CN1362154A Nano rheumatic osteodynia treating medicine and its preparation |
| 08/07/2002 | CN1362137A Nano spur-treating Gucining medicine and its preparation |
| 08/07/2002 | CN1362136A Nano Jingfukang medicine and its preparation |
| 08/07/2002 | CN1362134A Nano blood stasis arthralgia treating medicine and its preparation |
| 08/07/2002 | CN1362129A Nano bone-setting medicine and its preparation |
| 08/07/2002 | CN1362122A Nano fracture-setting traumatic medicine and its preparation |
| 08/07/2002 | CN1362120A Nano wound-healing motoginseng medicine and its preparation |
| 08/07/2002 | CN1362111A Nano Guzhining medicine and its preparation |
| 08/07/2002 | CN1362071A Medicine powder for treating bone injury fast |
| 08/07/2002 | CN1362068A Rheumatoid disease treating capsule |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |